Great Lakes Advisors, LLC Innoviva, Inc. Transaction History

Great Lakes Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$15.39 - $20.25 $202,101 - $265,923	-13,132 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$15.91 - $18.72 $208,930 - $245,831	13,132 New	13,132 $227,000
Q1 2020 May 08, 2020	SELL	$8.11 - $15.23 $1.87 Million - $3.52 Million	-231,007 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$10.28 - $14.38 $2.37 Million - $3.32 Million	231,007 New	231,007 $3.27 Million

225

78.8M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.3B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.